Zinc 1,4,8,11,15,18,22,25-octabutoxy-29H,31H-phthalocyanine
Zinc 1,4,8,11,15,18,22,25-octabutoxy-29H,31H-phthalocyanine structure
|
Common Name | Zinc 1,4,8,11,15,18,22,25-octabutoxy-29H,31H-phthalocyanine | ||
|---|---|---|---|---|
| CAS Number | 107227-89-4 | Molecular Weight | 1154.75000 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C64H80N8O8Zn | Melting Point | 185ºC (dec.)(lit.) | |
| MSDS | Chinese USA | Flash Point | N/A | |
|
Tumour-localising and -photosensitising properties of a novel zinc(II) octadecylphthalocyanine.
Br. J. Cancer 74(12) , 1891-9, (1996) 1,4,8,11,15,18,22,25-Octadecylphthalocyaninato zinc(II), ZnODPc, incorporated into a Cremophor emulsion, was assayed for its pharmacokinetic and phototherapeutic properties in Balb/c mice bearing an intramuscularly transplanted MS-2 fibrosarcoma. The phthaloc... |
|
|
Photoproperties of alkoxy-substituted phthalocyanines with deep-red optical absorbance.
Photochem. Photobiol. 50(3) , 277-82, (1989) Triplet-state properties of 1,4,8,11,15,18,22,25-octa-n-butoxyphthalocyanine and its zinc derivative were determined for the first time. The T1 state of the metal-free phthalocyanine was characterized by a short lifetime (tau T = 17 microseconds) and low quan... |
|
|
Tumour-localizing and tumour-photosensitizing properties of zinc(II)-octapentyl-phthalocyanine.
J. Photochem. Photobiol. B, Biol. 39(3) , 279-84, (1997) Zn(II)-octapentyl-phthalocyanine (ZnOPPc), incorporated into a Cremophor oil emulsion, was found to be a highly selective tumour-targeting agent (50-fold larger concentration in the tumour than in the peritumoral tissue) when injected at a dose of 1.46 mumol ... |
|
|
Relative contributions of apoptosis and random necrosis in tumour response to photodynamic therapy: effect of the chemical structure of Zn(II)-phthalocyanines.
J. Photochem. Photobiol. B, Biol. 43(3) , 181-5, (1998) Zn(II)-phthalocyanines (ZnPc) and its octapentyl (ZnOPPc) and octadecyl (ZnODPc) derivatives have been intravenously injected at a dose of 1.46 mumol/kg into female Balb/c mice bearing an intramuscularly transplanted MS-2 fibrosarcoma. Pharmacokinetic studies... |